• Due Diligence -- Assessment of a specific company's competitive advantage, market opportunity, product pipeline, intellectual property, and exit strategy potential to minimize investment risk;
  
• Start-up Acceleration -- Proven methodologies to clarify value propositions and develop a realistic product strategy, revenue model, and business plan to accelerate fundraising process and create a solid foundation for success;
  
• Product Licensing and Partnering -- Find partners for inlicensing and outlicensing of products utilizing our extensive network of big pharma, biotech, start-ups and niche players;
  
• Targeted Fundraising -- Make the most of each investor meeting by optimizing corporate presentations and leveraging our extensive network of private and public investors;
  
• Technology and Market Assessments -- Evaluate your pipeline for strengths and weaknesses then expand your business through in-licensing, out-licensing, or strategic partnerships;
  
• On-site Briefings -- Comprehensive interactive seminars on neurotechnology companies, pipelines and technologies to keep your team and customers abreast of trends shaping the market and improve your strategic planning process;
  
• Custom Research -- In-depth answers to company, market, or technology specific questions tailored to your needs.

Clients receive a comprehensive view of the $120 billion neurotechnology industry through detailed reports and timely interactions. Our team leverages a proprietary industry taxonomy, exclusive data, qualitative scenarios, and extensive industry relationships to deliver robust, actionable information. NeuroInsights is independent and unbiased, with no private or public equity in neurotechnology firms.

For more information, contact Casey Lynch at (415) 229-3225 or clynch@neuroinsights.com.